In this scenario, Lorkiewicz et al. (74) proposed to include BDNF among biomarkers of COVID-19-derived depression, whereas De Sousa et al. (75) underlined how the rise of BDNF levels, induced by physical activity, was crucial for maintaining good mental health after COVID-19 syndrome. The gene discussed is BDNF; the disease is depressive symptom measurement.